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Abstract: Cryptococcosis	is	a	common	fungal	infection	in	immunocompromised	patients,	caused	by	genus	Cryptococcus,	pre-
senting	with	meningitis,	pneumonia,	and	skin	lesions.	Cutaneous	presentation	can	be	varied,	but	specifically	in	solid	organ	
transplant	recipients	 (iatrogenically	 immunocompromised),	cryptococcosis	should	always	be	considered	 in	the	differential	
diagnosis	of	cellulitis-like	lesions,	since	the	delay	in	diagnosis	leads	to	worse	prognosis	and	fatal	outcome.	We	report	four	
cases	of	cryptococcosis	with	cutaneous	manifestation	not	only	for	its	rarity,	but	also	to	emphasize	the	important	role	of	the	
dermatologist in the diagnosis of this disease. 
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INTRODUCTION
Cryptococcosis is an infection caused by opportunistic and 
encapsulated fungi of the genus Cryptococcus.1 Cryptococcus gattii 
species is most commonly responsible for cryptococcosis in immu-
nocompetent	 individuals,	 while	 Cryptococcus neoformans is more 
common	in	 immunocompromised	patients.	However,	both	can	be	
found	in	any	patient,	and	cause	meningitis,	pneumonia	and	cuta-
neous lesions.2–4
Cryptococcosis	 can	present	with	 skin	 lesions	 that	 are	 sec-
ondary	 to	 systemic	 hematogenous	 spread	 or	 primary,	 being	 the	
latter rarer.3,5 The clinical presentation of cutaneous lesions can be 
varied,	therefore	there	are	no	typical	lesions	of	this	infection.3 In the 
immunocompromised	patients,	cryptococcosis	must	always	be	con-
sidered	in	the	differential	diagnosis	of	cellulitis-like	or	molluscum	
contagiosum-like	lesions,	because	the	delay	in	diagnosis	can	lead	to	
a worse prognosis.6
We report four cases of systemic cryptococcosis with varied 
cutaneous	presentations,	including	a	bacterial	cellulitis-like	lesion,	
in	renal	transplant	patients,	showing	the	many	forms	of	this	infre-
quent	infection	in	the	skin	and	the	importance	of	the	dermatologist	
for	 their	 identification.	This	 infection	can	progress	 to	death	 if	not	
treated early. 
CASE REPORT
Cutaneous cryptococcosis was diagnosed in four male pa-
tients seen during dermatological interconsultations of a tertiary 
hospital,	with	a	mean	age	of	41	years.	Three	were	renal	transplant	
patients,	one	of	whom	also	had	AIDS;	the	fourth	patient	had	no	di-
agnosed	comorbidities	(Table	1).	All	progressed	during	admission	
with	skin	lesions,	that	were	the	reason	for	dermatology	interconsul-
tation.	In	three	of	them,	the	lesions	themselves	were	the	reason	for	
hospital admission. 
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All	renal	 transplant	patients	were	under	 immunosuppres-
sant	 treatment.	 Patient	 1	 was	 taking	 mycophenolate	 mofetil	 and	
prednisone;	patient	3	mycophenolate	sodium,	tacrolimus	and	pred-
nisone;	and	patient	4,	azathioprine,	tacrolimus	and	prednisone.	Pa-
tient	1	was	also	on	antiretroviral	therapy	for	HIV	with	lamivudine,	
zidovudine	and	lopinavir/ritonavir	(Table	1).
On	 dermatological	 examination,	 patient	 1	 had	 brown	
plaques	covered	with	normochromic	nodules	with	smooth	surface	
on	the	anterior	aspect	of	the	legs;	patient	2	had	erythematous,	firm	
nodules with crusts and hemorrhagic dots on the left eyebrow and 
forearm;	patient	3	had	a	red-brown	plaque	with	mild	scaling	on	the	
left	leg;	and	patient	4	had	five	firm	red-purple	plaques	on	the	medi-
al	aspect	of	the	left	knee,	forearm	and	hip,	and	right	leg	and	thigh	
(Figures	1	and	2).
A	 biopsy	was	 taken	 from	 the	 lesions	 of	 the	 patients,	 and	
histopathology	confirmed	the	diagnosis	of	cryptococcosis	in	all	cas-
es	 (Figure	 3).	Cultures	 of	 the	 biopsy	 specimens	were	 positive	 for	
Cryptococcus	 in	 three	 cases	and	negative	 in	one.	All	patients	were	
diagnosed with disseminated cryptococcosis with extracutaneous 
involvement.	All	patients	had	central	nervous	system	involvement,	
and patients 2 and 4 also had the lungs affected. 
Treatment	was	started	with	amphotericin	B	and	fluconazole	
for	patients	1,	2	and	3	for	two	weeks,	then	maintenance	therapy	with	
fluconazole	 alone.	Patient	 4	 received	amphotericin	B	and	flucyto-
sine	for	two	weeks,	and	maintenance	therapy	was	made	with	flu-
conazole	alone.	
DISCUSSION
Cryptococcus infection usually occurs after inhalation of 
the	 fungus,	with	deposition	of	 spores	 into	 the	pulmonary	alveoli.	
In	 immunocompetent	 individuals,	 the	 organism	develops	 a	poly-
saccharide capsule that interferes with phagocyte recognition and 
opsonization.	In	immunocompromised	individuals,	and	those	with	
cellular	immunity	deficiency	in	particular,	there	can	be	hematoge-
nous	dissemination	particularly	to	the	central	nervous	system,	but	
also	to	kidneys,	bones	and	skin.5	The	systemic	form	is	defined	as	the	
involvement	of	two	or	more	non-adjacent	areas.6
Skin	 and	 soft	 tissue	 involvement	 is	 relatively	 rare	 (10%	a	
20%)	 but	 is	 almost	 always	 considered	 a	marker	 for	 disseminated	
disease,	and	can	sometimes	precede	the	diagnosis	of	systemic	infec-
tion.7,8	Cutaneous	clinical	presentation	is	varied;	there	can	be	pap-
ules,	pustules,	nodules,	abscesses,	edema,	panniculitis,	ulcers	and	
cellulitis-like	and	molluscum	contagiosum-like	lesions.4,8 In immu-
nosuppressed	patients,	such	as	solid	organ	transplant	patients,	the	
cutaneous presentation can simulate other conditions such as bac-
terial	cellulitis	or	panniculitis,	clinically	indistinguishable,	in	many	
taBle 1: Clinical data and laboratory tests results of four patients with disseminated cryptococcosis
Patient Age 
(years)
Comorbidity Medication Pathology Culture from 
skin specimen
Treatment
1 25 RTR 1 year and 3 months 
back	(kidney	loss	of	un-
known	 cause);	AIDS	 for	
6 years (CD4 85 cells/
mm3)
MMF and pred-
nisone;	 lamivu-
dine,	 zidovudine	
and lopinavir/
ritonavir
Cryptococco-
sis
Cryptococcus 
neoformans
Amphotericin	B	
and	fluconazole
2 38 No comorbidities - Cryptococco-
sis
Cryptococcus 
neoformans
Amphotericin	B	
and	fluconazole
3 47 RTR 3 years and 8 
months	 back	 (kidney	
loss	secondary	to	HTN)
MFNa,	tacrolimus	
and prednisone
Cryptococco-
sis
Cryptococcus 
spp.
Amphotericin	B	
and	fluconazole
4 56 RTR	7	months	back	(kid-
ney loss secondary to 
HTN)
Azathioprine,	 tac-
rolimus and pred-
nisone
Cryptococco-
sis
Negative Amphotericin	B	
and	flucytosine;	
then,	 flucona-
zole
RTR:	renal	transplant	recipient/AIDS:	acquired	immunodeficiency	syndrome/HTN:	systemic	hypertension	/MMF:	mycophenolate	
mofetil/MFNa: mycophenolate sodium
FIgure 1: A: Brown	plaques	on	the	anterior	aspect	of	the	legs,	with	
overlying	normochromic,	smooth	surfaced	nodules;	B and C: ery-
thematous	firm	nodules	on	the	eyebrow	(B) and forearm (C) with 
crusts and hemorrhagic dots
FIgure 2: A: Erythematous	plaque	on	the	left	leg,	with	mild	scaling; 
B and C: red-purple	plaque,	hardened	on	palpation,	on	the	medial	
aspect	of	the	knee (B) and forearm (C)
FIgure 3: A:	Skin	biopsy	from	the	forearm	with	a	granulomatous	
inflammatory	infiltrate	in	the	dermis,	with	neutrophils	and	a	large	
amount of fungi (Hematoxylin &	eosin,	X40);	B:	In	detail,	the	
granuloma with suppuration and fungi with refringent capsule 
(Hematoxylin &	eosin,	X400);	C: Fungi capsules were stained red 
by	the	special	staining	Mayer’s	mucicarmine	(X400).
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cases leading to delay in diagnosis and appropriate treatment.1,6–9
Diagnosis	can	be	made	by	microscopy,	culture	of	secretions,	
histopathology,	 serology	 or	 PCR.3,7 The recommended treatment 
for	disseminated	infection	must	include	three	phases:	1)	induction,	
with	amphotericin	B	(liposomal,	if	available)	associated	with	5-flu-
cytosine	for	two	weeks;	2)	consolidation,	with	high	doses	of	fluco-
nazole	 (400mg/day	 to	 800mg/day)	 for	 eight	 to	 10	weeks;	 and	 3)	
maintenance,	with	fluconazole	(200mg/day)	for	six	to	12	months.10 
We present a series of cases of cryptococcosis with cutane-
ous	manifestation	 because	 of	 its	 rarity	—	 since	 only	 a	 small	 per-
centage	 of	patients	will	 develop	 it	—,	 and	 the	 importance	 of	dif-
ferentiation	with	other	more	common	cutaneous	infections,	such	as	
bacterial cellulitis and molluscum contagiosum. It is a severe sys-
temic	infection,	that	can	progress	in	an	unfavorable	way	when	the	
diagnosis is delayed. We highlight the important role of the derma-
tologist in these cases.q
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